Robert Clayton Robbins

Robert Clayton Robbins's AcademicInfluence.com Rankings

Medical

#2627

World Rank

#3058

Historical Rank

Cardiology

#245

World Rank

#251

Historical Rank

Pharmacology

#277

World Rank

#325

Historical Rank

medical Degrees

Robert Clayton Robbins

Philosophy

#7540

World Rank

#10769

Historical Rank

Logic

#4592

World Rank

#5903

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Robert Clayton Robbins's Degrees

Doctorate Medicine Stanford University
PhD Pharmacology Stanford University

Why Is Robert Clayton Robbins Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Clayton Robbins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium (2004) (1787)
Human tissue-engineered blood vessels for adult arterial revascularization (2007) (977)
Management of Patients With Intramural Hematoma of the Thoracic Aorta (1993) (881)
A nonviral minicircle vector for deriving human iPS cells (2010) (721)
Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy (2012) (612)
Stem cell transplantation: the lung barrier. (2007) (593)
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. (2013) (566)
In vivo detection and imaging of phosphatidylserine expression during programmed cell death. (1998) (546)
Novel Index for Invasively Assessing the Coronary Microcirculation (2003) (523)
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells (2009) (516)
Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity (2013) (473)
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease (2010) (423)
Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction (2003) (352)
Consensus Conference Report (2002) (351)
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. (2005) (349)
Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium (2005) (332)
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts (2008) (305)
Risk factors for the development of obliterative bronchiolitis after lung transplantation. (1996) (283)
Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays (2013) (277)
Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. (2011) (277)
Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes (2005) (275)
Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells (2011) (260)
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes (2008) (236)
Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections? (2002) (234)
Differentiation, Survival, and Function of Embryonic Stem Cell–Derived Endothelial Cells for Ischemic Heart Disease (2007) (228)
Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. (2002) (227)
Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. (1996) (223)
Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia (2008) (221)
Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury (2005) (218)
Hepatocyte Growth Factor or Vascular Endothelial Growth Factor Gene Transfer Maximizes Mesenchymal Stem Cell–Based Myocardial Salvage After Acute Myocardial Infarction (2009) (203)
Collagen Matrices Enhance Survival of Transplanted Cardiomyoblasts and Contribute to Functional Improvement of Ischemic Rat Hearts (2006) (202)
Effects of cell number on teratoma formation by human embryonic stem cells (2009) (198)
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors (2011) (195)
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation (2013) (194)
Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. (2001) (191)
Imaging survival and function of transplanted cardiac resident stem cells. (2009) (182)
miR-29b Participates in Early Aneurysm Development in Marfan Syndrome (2012) (173)
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. (1999) (170)
Elevated pulmonary vascular resistance and cardiac transplantation. (1987) (163)
Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. (1996) (157)
Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. (2004) (154)
Microvascular Resistance Is Not Influenced by Epicardial Coronary Artery Stenosis Severity: Experimental Validation (2004) (153)
Wound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil‐Based Regimen in Cardiac Transplant Recipients (2006) (150)
In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. (2008) (149)
Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. (1998) (145)
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone (2001) (144)
Molecular Imaging of Bone Marrow Mononuclear Cell Homing and Engraftment in Ischemic Myocardium (2007) (142)
Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation (2011) (142)
Comparison of Transplantation of Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stem Cells in the Infarcted Heart (2009) (139)
Obliterative bronchiolitis after lung and heart-lung transplantation. (1995) (135)
Twenty-year clinical experience with porcine bioprostheses. (1996) (132)
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. (1999) (131)
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. (1996) (126)
In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. (2008) (125)
Arrhythmias and thromboembolic complications after the extracardiac Fontan operation. (1998) (122)
A Report of Two Hundred Twenty Cases of Regional Anesthesia in Pediatric Cardiac Surgery (2000) (122)
Comparison of Coronary Thermodilution and Doppler Velocity for Assessing Coronary Flow Reserve (2003) (119)
Absent Secretion to Vasoactive Intestinal Peptide in Cystic Fibrosis Airway Glands* (2002) (118)
Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction (2009) (117)
Multicenter experience with the thoratec ventricular assist device in children and adolescents. (2001) (114)
Thirty years of cardiac transplantation at Stanford university. (1999) (113)
Dimethylarginine Dimethylaminohydrolase Overexpression Suppresses Graft Coronary Artery Disease (2005) (112)
Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t (2006) (112)
Local MicroRNA Modulation Using a Novel Anti-miR-21–Eluting Stent Effectively Prevents Experimental In-Stent Restenosis (2015) (107)
Hyposecretion, Not Hyperabsorption, Is the Basic Defect of Cystic Fibrosis Airway Glands*♦ (2006) (106)
The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. (1998) (105)
They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. (2005) (104)
Invasive aspergillosis in the setting of cardiac transplantation. (2003) (102)
Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction (2008) (102)
Microfluidic Single-Cell Analysis Shows That Porcine Induced Pluripotent Stem Cell–Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation (2012) (102)
Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. (1996) (101)
Does Profound Hypothermic Circulatory Arrest Improve Survival in Patients With Acute Type A Aortic Dissection? (2002) (101)
Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. (2005) (100)
Heart retransplantation: the 25-year experience at a single institution. (1995) (99)
Heart transplantation: a thirty-year perspective. (2002) (99)
Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. (2007) (98)
Lung transplantation: a decade of experience. (2005) (97)
Severe tricuspid regurgitation after heart transplantation. (2001) (97)
Preclinical Derivation and Imaging of Autologously Transplanted Canine Induced Pluripotent Stem Cells* (2011) (95)
Short Hairpin RNA Interference Therapy for Ischemic Heart Disease (2008) (95)
Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair. (2003) (94)
Genome Editing of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells With Zinc Finger Nucleases for Cellular Imaging (2012) (92)
Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. (2004) (91)
Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury (2005) (91)
Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience. (2007) (88)
Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training. (2009) (88)
Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. (2006) (87)
Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. (2007) (87)
LAD-ligation: a murine model of myocardial infarction. (2009) (85)
Dichloroacetate prevents restenosis in preclinical animal models of vessel injury (2014) (81)
Ten- and 20-year survivors of pediatric orthotopic heart transplantation. (2006) (81)
Imaging gene expression in human mesenchymal stem cells: from small to large animals. (2009) (80)
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. (2007) (80)
Upregulation of Bcl-2 Through Caspase-3 Inhibition Ameliorates Ischemia/Reperfusion Injury in Rat Cardiac Allografts (2001) (79)
Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. (2010) (78)
Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. (2006) (78)
Adenoviral Human BCL-2 Transgene Expression Attenuates Early Donor Cell Death After Cardiomyoblast Transplantation Into Ischemic Rat Hearts (2006) (76)
Double Knockdown of Prolyl Hydroxylase and Factor-Inhibiting Hypoxia-Inducible Factor With Nonviral Minicircle Gene Therapy Enhances Stem Cell Mobilization and Angiogenesis After Myocardial Infarction (2011) (75)
In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides (2007) (74)
Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion (2010) (74)
Particulate emboli capture by an intra-aortic filter device during cardiac surgery. (2000) (73)
Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. (2005) (73)
Early Stem Cell Engraftment Predicts Late Cardiac Functional Recovery: Preclinical Insights From Molecular Imaging (2012) (72)
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. (2004) (71)
Outcome analysis of donor gender in heart transplantation. (2006) (70)
VEGF gene delivery for treatment of ischemic cardiovascular disease. (2002) (70)
Long-term results of heart transplantation in patients older than 60 years. (2003) (70)
Overexpression of Human Copper/Zinc Superoxide Dismutase (SOD1) Suppresses Ischemia–Reperfusion Injury and Subsequent Development of Graft Coronary Artery Disease in Murine Cardiac Grafts (2004) (70)
Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function. (2011) (68)
Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue. (2013) (67)
Intermittent hypothermic asanguineous cerebral perfusion (cerebroplegia) protects the brain during prolonged circulatory arrest. A phosphorus 31 nuclear magnetic resonance study. (1990) (64)
Composite valve graft versus separate aortic valve and ascending aortic replacement: is there still a role for the separate procedure? (1997) (63)
Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations (2002) (62)
Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. (2004) (62)
The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. (1995) (62)
Transplantation for Idiopathic Pulmonary Arterial Hypertension: Improvement in the Lung Allocation Score Era (2013) (62)
nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis (2009) (60)
Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. (1996) (60)
IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model (2010) (58)
αB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion. (2011) (57)
Heart-lung transplantation for primary pulmonary hypertension. (1999) (56)
In Vivo Functional and Transcriptional Profiling of Bone Marrow Stem Cells After Transplantation Into Ischemic Myocardium (2012) (56)
Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. (2007) (56)
Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability. (2000) (54)
Long-term results of combined heart-lung transplantation: the Stanford experience. (1994) (53)
Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data. (2004) (53)
Haematopoietic stem cells and repair of the ischaemic heart. (2005) (52)
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-Defined Morbidity and Mortality Associated With Pediatric Ventricular Assist Device Support at a Single US Center: The Stanford Experience (2010) (52)
SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. (2015) (52)
In Vivo Imaging of Acute Cardiac Rejection in Human Patients Using 99mTechnetium Labeled Annexin V (2001) (52)
The impact of brain death on survival after heart transplantation: time is of the essence (2003) (51)
Outcome in Cardiac Recipients of Donor Hearts With Increased Left Ventricular Wall Thickness (2007) (50)
Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. (2009) (50)
Cardiac valve replacement in children: a twenty-year series. (1988) (50)
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease. (1997) (50)
Thoratec Ventricular Assist Devices in Pediatric Patients: Update on Clinical Results (2005) (50)
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. (2000) (49)
Durability of the Hancock MO bioprosthesis compared with standard aortic valve bioprostheses. (1995) (49)
Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery After Myocardial Infarction (2010) (48)
Radionuclide imaging of acute lung transplant rejection with annexin V. (2000) (47)
In Vivo Visualization of Cardiac Allograft Rejection and Trafficking Passenger Leukocytes Using Bioluminescence Imaging (2005) (47)
Zinc-Mediated Reduction of Apoptosis in Cardiac Allografts (2000) (46)
L-arginine polymers inhibit the development of vein graft neointimal hyperplasia. (2001) (46)
The totally implantable novacor left ventricular assist system. (2001) (46)
Matrix Metalloproteinase Inhibition Decreases Ischemia‐Reperfusion Injury After Lung Transplantation (2004) (46)
Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. (2007) (44)
Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. (2001) (44)
Metabolism of the heart and brain during hypothermic cardiopulmonary bypass. (1991) (44)
Suppression of Graft Coronary Artery Disease by a Brief Treatment With a Selective &egr;PKC Activator and a &dgr;PKC Inhibitor in Murine Cardiac Allografts (2004) (42)
Induction Therapy for Pediatric and Adult Heart Transplantation: Comparison Between OKT3 and Daclizumab (2005) (42)
Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease. (2012) (42)
Trends in invasive disease due to Candida species following heart and lung transplantation (2009) (41)
Randomized, Prospective Assessment of Bioprosthetic Valve Durabilit Hancock Versus Carpentier‐Edwards Valves (1993) (40)
NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium. (2015) (40)
Twenty‐Year Survivors of Heart Transplantation at Stanford University (2008) (40)
Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum (2016) (40)
Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds. (2011) (40)
Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. (1998) (39)
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. (1999) (39)
Relationship of cerebral and myocardial intracellular pH to blood pH during hypothermia. (1991) (39)
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model. (2007) (39)
In vivo serial evaluation of superparamagnetic iron‐oxide labeled stem cells by off‐resonance positive contrast (2008) (38)
Multimodality Evaluation of the Viability of Stem Cells Delivered Into Different Zones of Myocardial Infarction (2008) (37)
Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. (2002) (36)
Primary repair of complete sternal cleft with pectoralis major muscle flaps. (1996) (36)
Safe Genetic Modification of Cardiac Stem Cells Using a Site-Specific Integration Technique (2012) (36)
Superior vena cava syndrome after heart transplantation: percutaneous treatment of a complication of bicaval anastomoses. (1998) (36)
Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells (2011) (36)
Late results of aortic valvotomy for congenital valvar aortic stenosis. (1990) (36)
Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience. (2002) (36)
Costimulation‐adhesion blockade is superior to Cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation (2013) (36)
Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy. (2015) (35)
Influence of mast cells on outcome after heterotopic cardiac transplantation in rats (2007) (35)
Novel Immunosuppression: R348, a JAK3- and Syk-Inhibitor Attenuates Acute Cardiac Allograft Rejection (2008) (35)
The Novacor Left Ventricular Assist System: Clinical Experience from the Novacor Registry (2001) (34)
The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. (1998) (33)
Manganese‐guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability (2009) (32)
Nuclear factor-kappaB transcription factor decoy treatment inhibits graft coronary artery disease after cardiac transplantation in rodents. (2000) (32)
Human Leukocyte Antigen I Knockdown Human Embryonic Stem Cells Induce Host Ignorance and Achieve Prolonged Xenogeneic Survival (2011) (32)
Review of heart-lung transplantation at Stanford. (2010) (31)
Superoxide Dismutase Mimetic M40401 Reduces Ischemia-Reperfusion Injury and Graft Coronary Artery Disease in Rodent Cardiac Allografts (2004) (30)
Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. (2003) (30)
In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts. (2007) (30)
In vivo molecular MRI of cell survival and teratoma formation following embryonic stem cell transplantation into the injured murine myocardium (2011) (29)
Progression of Alloresponse and Tissue‐Specific Immunity during Graft Coronary Artery Disease (2005) (29)
The ubiquitin-proteasome system: A potential therapeutic target for heart failure. (2017) (29)
Dual Manganese-Enhanced and Delayed Gadolinium-Enhanced MRI Detects Myocardial Border Zone Injury in a Pig Ischemia-Reperfusion Model (2011) (29)
New directions in cardiac transplantation. (2006) (29)
Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells. (2008) (28)
Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction. (2005) (28)
Cardiac xenotransplantation in primates. (1987) (28)
Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? (2006) (27)
The utility of annual surveillance bronchoscopy in heart-lung transplant recipients. (1995) (27)
A Novel Cardioprotective Agent in Cardiac Transplantation: Metformin Activation of AMP-Activated Protein Kinase Decreases Acute Ischemia-Reperfusion Injury and Chronic Rejection (2011) (27)
The use of advanced‐age donor hearts adversely affects survival in pediatric heart transplantation (1999) (27)
Indirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy (2010) (27)
Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. (2013) (26)
Bridge to transplant with the Novacor left ventricular assist system. (1999) (26)
Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts. (2000) (25)
Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. (1999) (24)
Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium. (2009) (24)
Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. (2002) (23)
Introducing the first polymer-free leflunomide eluting stent. (2008) (23)
Zinc chloride-mediated reduction of apoptosis as an adjunct immunosuppressive modality in cardiac transplantation. (2002) (23)
Leflunomide prolongs pulmonary allograft and xenograft survival. (1995) (23)
Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. (2004) (23)
Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates. (1998) (23)
Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase (2003) (23)
Hyperacute rejection of hDAF‐transgenic pig organ xenografts in cynomolgus monkeys: influence of pre‐existing anti‐pig antibodies and prevention by the αGAL glycoconjugate GAS914 (2004) (22)
Positron emission tomography imaging of conditional gene activation in the heart. (2007) (22)
Effect of Inhaled Tacrolimus on Cellular and Humoral Rejection to Prevent Posttransplant Obliterative Airway Disease (2007) (22)
Experimental orthotopic tracheal transplantation: The stanford technique (2007) (21)
Sustained Inhibition of &egr; Protein Kinase C Inhibits Vascular Restenosis After Balloon Injury and Stenting (2010) (21)
Heart-lung versus double-lung transplantation for suppurative lung disease. (2000) (21)
Quantification of mechanical stabilization for the performance of off-pump coronary artery surgery. (2003) (21)
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. (2003) (20)
Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators. (2005) (20)
Techniques in Orthotopic Cardiac Transplantation: A Review (2001) (20)
Chylothorax after heart/lung transplantation. (2004) (20)
Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model? (2007) (19)
Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis (2001) (19)
Ex Vivo Antisense Oligonucleotides to Proliferating Cell Nuclear Antigen and Cdc2 Kinase Inhibit Graft Coronary Artery Disease (2000) (19)
The Potassium Channel KCa3.1 as New Therapeutic Target for the Prevention of Obliterative Airway Disease (2013) (19)
Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model. (2002) (19)
Pediatric heart-lung transplantation: intermediate-term results. (1996) (19)
Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts. (2001) (19)
In vivo monitoring of myoblast transplantation into rat myocardium. (2001) (18)
Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease. (2001) (18)
Cervical aortic arch with pseudocoarctation: presentation with spontaneous rupture. (1999) (18)
Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model. (1998) (18)
Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation. (2010) (18)
Gastric pacing for severe gastroparesis in a heart-lung transplant recipient. (2004) (17)
Overexpression of Human Bcl-2 in Syngeneic Rat Donor Lungs Preserves Posttransplant Function and Reduces Intragraft Caspase Activity and Interleukin-1&bgr; Production (2005) (17)
Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation. (1990) (17)
Corrigendum to “Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury” [Eur J Cardiothorac Surg 29 (2006) 50–55] (2006) (17)
A Novel JAK3 Inhibitor, R348, Attenuates Chronic Airway Allograft Rejection (2009) (16)
Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment. (2005) (16)
Will minimally invasive valve replacement ever really be important? (2004) (16)
Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides. (1998) (16)
Mechanical Support for Acutely Failed Heart or Lung Grafts (2000) (15)
Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease. (2005) (15)
Tolerance to cardiac allografts induced in utero with fetal liver cells. (1996) (14)
ICAM-1 affects reperfusion injury and graft function after cardiac transplantation. (1999) (14)
Potential role of γδ T cell-derived IL-17 in acute cardiac allograft rejection. (2012) (14)
Ethical implications of heart transplantation in elderly patients. (2001) (14)
Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part I. Reporter Gene Design, Characterization, and Optical in Vivo Imaging of Bone Marrow Stromal Cells after Myocardial Infarction. (2016) (13)
Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants (2003) (13)
Abstract 13618: Sustained Inhibition of Epsilon Protein Kinase C Inhibits Vascular Restenosis After Balloon Injury and Stenting (2010) (13)
Successful repair of blunt injury of aortic arch branches in the setting of bovine arch. (2006) (13)
Significant Reduction of Acute Cardiac Allograft Rejection by Selective Janus Kinase-1/3 Inhibition Using R507 and R545 (2012) (13)
Are there predictors of death at the time of listing for lung transplant (2002) (13)
Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model. (2011) (13)
Cardiac xenograft survival in baboons treated with cyclosporine in combination with conventional immunosuppression. (1987) (13)
Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. (2005) (12)
Cardiac transplantation for hypertrophic cardiomyopathy associated with Sengers syndrome. (1995) (12)
Risk factors for death after lung transplant in the US (2003) (12)
Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation. (2001) (12)
The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. (2010) (11)
Immunobiology of Fibrin‐Based Engineered Heart Tissue (2015) (11)
Reduction of Vein Graft Disease Using Photodynamic Therapy with Motexafin Lutetium in a Rodent Isograft Model (2000) (11)
Hemodynamics and metabolism during surface-induced hypothermia in the dog: a comparison of pH management strategies. (1990) (11)
Prevention of transplant coronary artery disease by prenylation inhibitors. (2011) (11)
Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778 (2008) (10)
Short hairpin RNA gene silencing of prolyl hydroxylase-2 with a minicircle vector improves neovascularization of hindlimb ischemia. (2014) (10)
FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy. (2007) (10)
L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation. (2001) (10)
A Titratable Two-Step Transcriptional Amplification Strategy for Targeted Gene Therapy Based on Ligand-Induced Intramolecular Folding of a Mutant Human Estrogen Receptor (2014) (10)
Congenital diaphragmatic hernia associated with aortic coarctation. (1998) (10)
Survivors more than 10 years after heart transplantation in the cyclosporine era (2002) (10)
Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging. (2016) (10)
Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts. (2005) (9)
Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity. (2001) (9)
Abstract 15112: Microfluidic Single Cell Analysis Shows Porcine Induced Pluripotent Stem Cell-Derived Endothelial Cells Improve Myocardial Function by Paracrine Activation (2012) (9)
Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys. (2000) (9)
L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats. (2003) (9)
Alternative approach for use of a left ventricular assist device with a thrombosed prosthetic valve. (2002) (9)
Executive summary for the National Heart, Lung, and Blood Institute Working Group on next generation ventricular assist devices for destination therapy. (2005) (9)
Inhibition of Restenosis Development after Mechanical Injury: A New Field of Application for Malononitrilamides? (2006) (9)
Prostaglandin E2 inhibits in vitro and in vivo lymphocyte responses in allogeneic transplantation. (1990) (9)
Distinct cell-to-fiber junctions are critical for the establishment of cardiotypical phenotype in a 3D bioartificial environment. (2004) (9)
Successful bridge to transplant using the Berlin Heart left ventricular assist device in a 3-month-old infant. (2006) (9)
Comment on “Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response” (2007) (8)
EFFECTS OF AGI-1096, A NOVEL ANTIOXIDANT COMPOUND WITH ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE PROPERTIES, ON RODENT ALLOGRAFT ARTERIOSCLEROSIS (2004) (8)
Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts. (1999) (8)
Arterial switch and resection of hepatic hemangioendothelioma. (1995) (8)
A rodent model of in utero chimeric tolerance induction. (1997) (8)
Micro-CT for characterization of murine CV disease models. (2010) (8)
The road to clinical xenotransplantation: a worthwhile journey. (2004) (7)
Pre‐transplant blood transfusion induces tolerance to hamster cardiac xenografts in athymic nude rats (2001) (7)
Non-volume-loaded heart provides a more relevant heterotopic transplantation model. (2010) (7)
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model (2009) (7)
Heterotopic and Orthotopic Tracheal Transplantation in Mice used as Models to Study the Development of Obliterative Airway Disease (2010) (7)
Oral delivery of low molecular weight heparin in rat cardiac allografts. (1998) (7)
A novel platform device for rodent echocardiography. (2007) (7)
Elevated cyclic adenosine monophosphate ameliorates ischemia-reperfusion injury in rat cardiac allografts. (2003) (7)
Noninvasive imaging of hypoxia-inducible factor-1α gene therapy for myocardial ischemia. (2013) (7)
Alternative technique for salvage of donor lungs with insufficient atrial cuffs. (2009) (7)
Heart and Heart-Lung Transplantation: An Update (1996) (7)
A new large-animal model for research of graft vascular disease. (1998) (6)
Improvement in the Nutritional and Pulmonary Profiles of Cystic Fibrosis Patients Undergoing Bilateral Sequential Lung and Heart-Lung Transplantation (1997) (6)
Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy. (2010) (6)
Pleural disease in patients undergoing lung transplantation for cystic fibrosis. (1998) (6)
Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia. (2003) (6)
Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays − Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell (2013) (6)
Paradoxical embolism of a shotgun pellet. (1998) (6)
Role of molecular imaging in stem cell therapy for myocardial restoration. (2010) (5)
Erratum: Comparison of Coronary Thermodilution and Doppler Velocity for Assessing Coronary Flow Reserve (Circulation (November 4, 2003) 108 (2198-2200)) (2003) (5)
Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models. (2014) (5)
Direct inhibition of gastric electrolyte secretion by insulin, independent of hypoglycemia or the vagus (1966) (5)
The use of 99mtechnetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts☆ (2002) (5)
Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis. (2012) (5)
Donor cardiac allografts from p53 knockout mice exhibit apoptosis-independent prolongation of survival. (2002) (5)
Percutaneous In-Situ Coronary Artery Bypass (PICAB): A Novel Myocardial Revascularization Technique (1998) (5)
FAILURE OF DONOR‐SPECIFIC PRETRANSPLANT BLOOD TRANSFUSION TO PROLONG HETEROTOPIC CARDIAC ALLOGRAFT SURVIVAL IN RATS (1987) (5)
Cytokines interleukin 5 and GM-CSF in the BAL fluid of lung transplant patients. (1998) (5)
A few critical aspects--and Achilles heels--of tissue engineering approaches to restore injured myocardium. (2003) (5)
Pre‐transplant blood transfusion and cyclosporin A induce long‐term hamster cardiac xenograft survival in immunocompetent rats (2005) (5)
Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder (2016) (5)
1998 AATS Scientific Achievement Award recipient-Norman E. Shumway, MD, PHD. American Association for Thoracic Surgery. (1999) (4)
Hamster cardiac xenografts are protected against antibody mediated damage, early after transplantation to Lewis rats (2001) (4)
Theranostic effect of serial manganese‐enhanced magnetic resonance imaging of human embryonic stem cell derived teratoma (2012) (4)
Human plasma causes rapid dysfunction in ex vivo pig hearts. (1994) (4)
Norman E. Shumway (2000) (4)
Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation (2010) (4)
Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT). (2011) (4)
The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation (2016) (3)
Upper airway obstruction caused by low-grade tracheal papillary adenocarcinoma: an usual flow-volume loop pattern. (1996) (3)
Manganese-enhanced MRI detects live human amnion-derived mesenchymal stem cells in vivo after transplantation and restoration of myocardial function in a pig ischemia-reperfusion injury model (2012) (3)
Coronary Allograft Arteriosclerosis: Local MicroRNA Modulation Using a Novel Anti-Mir-21-Eluting Stent Prevents in-Stent Restenosis (2015) (3)
A Thirty-Year Perspective (2001) (3)
he role of recipient mast cells in acute and chronic ardiac allograft rejection in C 57 BL / 6-KitW-sh / Wsh mice (3)
Macrophages Infiltration is Associated with Maladaptive Remodeling of the Right Ventricle in an Experimental Model of Pulmonary Hypertension (2014) (3)
Perinatal induction of immunotolerance to cardiac and pulmonary allografts. (1997) (3)
Bcl-2-mediated inhibition of apoptosis in rat cardiac allografts worsens development of graft coronary artery disease. (2003) (3)
Abstract 9306: Site-Specific Reporter Gene Imaging of Stem Cell Transplantation: Early Engraftment Predicts Late Improvement in Cardiac Function (2011) (3)
Current Trends in Heart Transplantation (2007) (2)
Adenoviral upregulation of BCL-2 decreases oxidative stress and graft coronary artery disease in rat heart transplants (2002) (2)
Upregulation of BCL-2 via hyperbaric pressure transfection of TGF- beta1 ameliorates ischemia/reperfusion injury in rat cardiac allografts. (2001) (2)
Abstract 13231: Patient-Specific Induced Pluripotent Stem Cell as a Model for Familial Dilated Cardiomyopathy (2011) (2)
Abstract 5634: Molecular Imaging of Bone Marrow Mononuclear Cell Survival and Homing in Murine Peripheral Artery Occlusive Disease (2009) (2)
61 The Association between Poor Socioeconomic Status and Poor Long-Term Outcomes Following Heart Transplantation (2011) (2)
483 Lower Socioeconomic Status Predicts Poor Waitlist and Post-Heart Transplant Survival in Children (2011) (2)
Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? (2007) (2)
Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model. (1999) (2)
Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study (2003) (2)
Aortic root aneurysm due to donor cystic medial degeneration after heart-lung transplantation. (2006) (2)
Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells for regenerative therapies (2011) (2)
Monitoring brain oxygenation using time-of-flight spectroscopy (1998) (2)
Rapid and efficient feeder-free generation of human adipose stromal cell–derived induced pluripotent stem cells (hASC-iPSCs) (2009) (2)
409: Use of INTERMACS Criteria To Assess Major Clinical Outcomes in Children Bridged to Heart Transplant Using Mechanical Circulatory Support (2009) (2)
Twenty years of combined heart-lung transplantation at Stanford University (2002) (2)
321: Stem Cell Transplantation for the Ischemic Myocardium: Answering the Basic Questions of Bone Marrow Stromal Cell Migration, Homing and Survival (2008) (2)
Increased pressure for ex vivo transfection of antisense oligodeoxynucleotides in cardiac allografts improves transfection efficiency (1998) (2)
COADMINISTERED NEORAL AND THE NEW RAPAMYCIN DERIVATIVE, SDZ RAD, FOR NONHUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMCOKINETIC-BASED TRIALS TO MAXIMIZE EFFICACY AND TOLERABILITY (1998) (2)
Intraoperative echocardiography in valvular heart disease — quantitative study of left ventricular properties (1989) (1)
Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells (2011) (1)
IMPACT OF DONOR AGE ON BIOLOGICAL AND IMMUNOGENIC PROPERTIES OF MESENCHYMAL STROMAL CELLS (2015) (1)
Photodynamic therapy using motexafin lutetium in allograft coronary artery disease (2001) (1)
Targeting the JAK1/3 pathway to suppress acute allograft rejection (2011) (1)
461: Prevention and Inhibition but Not Reversion of Chronic Allograft Vasculopathy by FK778 (2008) (1)
230 Manganese guided cellular MRI of human embryonic stem cell viability (2008) (1)
Overrepresentation of Neuronal Development Pathways in Heart Failure Patients Who Dramatically Responded to Pharmaceutical Therapy (2008) (1)
330: Effects of the JAK3-Inhibitor R348 on Different Cell Types Involved in Obliterative Airway Disease (2009) (1)
Restorative effects of alpha-1A adrenergic are detectable using T2* and targeted nanoparticles in a mouse myocardial infarction (MI) model (2013) (1)
Mitochondrial Proteins Possess Antigenicity and Can Cause Rejection (2016) (1)
How to Engage in Departmental Strategic Planning (2020) (1)
Abstract 14887: Short-Term Costimulatory Molecule Blockade Promotes Long-Term Engraftment of Transplanted Human Embryonic Stem Derivatives and Improves Cardiac Recovery (2012) (1)
Embryonic Stem Cells and Myocardial Regeneration (2007) (1)
560: Stem cell transplantation and migration: The lung barrier (2007) (1)
Blood transfusion effect on xenograft survival in athymic nude rats is mediated by humoral factors. (2000) (1)
10 and 20-year long-term survival after pediatric orthotopic heart transplantation (2004) (1)
Treatment options for patients with severe myocardial failure: a review of the latest technology (1999) (1)
IN VIVO IMAGING OF APOPTOSIS DURING CARDIAC ALLOGRAFT REJECTION USING RADIOLABELED ANNEXIN V (1998) (1)
545 Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells for Regenerative Therapies (2011) (1)
Current trends in heart transplantation. (2007) (1)
EX VIVO BLOCKADE OF ENDOTHELIN‐1 INHIBITS GRAFT CORONARY ARTERY DISEASE IN A RODENT CARDIAC ALLOGRAFT MODEL.: Abstract# 725 (2000) (1)
The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts. (2002) (1)
Abstract 1096: Cytokine Enhancement with Hgf Or Vegf in the Infarct Border Zone is Key to Attenuating the Negative Remodelling after Myocardial Infarction (2008) (1)
256: Pacemaker Use Following Heart Transplantation (2008) (1)
(1138) - Pulmonary Hypertension: Macrophage Infiltration Corelates with Right Ventricular Remodeling in an Experimental Model of Pulmonary Hypertension (2017) (1)
HGF or VEGF gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction (2010) (1)
molecular imaging of bone marrow mononuclear Cell survival and Homing in a murine model of Peripheral Artery Disease (2010) (1)
400 Metabolic Modulation – A Feasible Concept To Tackle Intimal Proliferation? (2011) (1)
Bridge to heart transplantation: a comparison of ventricular assist device and inotropic support (2003) (1)
Brain functional imaging using time-of-flight optical spectroscopy (1998) (1)
Abstract 856: Genomic Profiling of Bone Marrow Cells Transplanted Into the Heart (2007) (1)
Effect of a novel anti-oxidant and anti-inflammatory compound on rodent allograft arteriosclerosis (2002) (1)
553: Inhaled immunosuppression with tacrolimus after airway transplantation (2007) (1)
A single center experience with heart retransplantation: the 29 year experience at a single institution (1997) (1)
Successful repair of tracheal dehiscence after heart-lung transplantation. (2005) (1)
Abstract 3981: MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease (2009) (1)
Change you can count on. (2013) (1)
Abstract 2713: Molecular Imaging of Cardiac Stem Cell Mediated Angiogenic Gene Therapy (2006) (1)
228: Optimizing Aerosolized Tacrolimus To Prevent Cellular and Humoral Rejection (2008) (1)
Oxidative stress and graft coronary artery disease: Early factors contributing to late outcomes (2001) (1)
Response to letter regarding article, "transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era". (2014) (1)
20-year survivors of heart transplantation at Stanford University (2009) (1)
Translational models: A humanized model to study the development of intimal hyperplasia after stenting (2012) (0)
Stimulation of paracrine pathways enhances embryonic stem cell engraftment and differentiation in the injured heart (2004) (0)
TC99M MCP-1 imaging of chronic rejection in rat cardiac allografts. (2001) (0)
255 Targeting the JAK1/3 Pathway To Suppress Acute Allograft Rejection (2011) (0)
49 Five Years of Lung Transplantation Since the Implementation of the Lung Allocation Score: A Comparative Analysis of Patient Characteristics and Outcomes (2012) (0)
The effect of FK778 on the development and progression of chronic transplant vasculopathy (2008) (0)
135: Experimental Transplantation: Novel Immunosuppression Using the JAK3-Inhibitor R348 (2010) (0)
Abstract 1016: Regenerative Cellular Therapy: How To Enrich The Mesenchymal Stem Cell Content In The Periinfarction Zone After Myocardial Infarction (2007) (0)
Heart and lung transplantation: Novel immunosuppression using the JAK3-inhibitor R348 (2009) (0)
Abstract 18777: A Novel MicroRNA Cocktail for Improving Survival of Transplanted Cardiac Progenitor Cells (2010) (0)
MATRIX METALLOPROTEINASE INHIBITION DECREASES ISCHEMIA‐REPERFUSION INJURY AFTER LUNG TRANSPLANTATION.: Abstract# 738 (2000) (0)
406 Translational Models: A Humanized Model To Study the Development of Obliterative Airway Disease (2012) (0)
Heart-lung transplantation at stanford university since 1981 (2009) (0)
Molecular imaging and transcriptional profiling of bone marrow cell therapy for ischemic heart disease (2007) (0)
566: Local, Graft Specific Immunosuppression: Experimental Data on Aerosolized Tacrolimus for Airway Transplantation (2009) (0)
Aerosolized immunosuppression with tacrolimus prevents acute rejection and posttransplant obliterative airway disease (2008) (0)
Abstract 10479: Improved Survival with Lung and Heart-Lung Transplantation in Idiopathic Pulmonary Hypertension Patients: Analysis of the United Network for Organ Sharing Database (2011) (0)
291 Immunogenicity of Umbilical Cord Lining-Derived Mesenchymal Stromal Cells (2012) (0)
Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation. (2001) (0)
DCA Alleviates Myointima Formation via a Redox-sensitive c-myc Pathway (2015) (0)
Inhaled Immunosuppression Using the Novel JAK1/3 Inhibitor R507 (2013) (0)
Abstract 11891: Chronic Allograft Vasculopathy is Promoted by Increased Mitochondrial Activity (2012) (0)
JAK3-inhibition: Suppressing immune cells while preserving epithelial cells (2012) (0)
Upregulation of BCL-2 ameriorates ischemia reperfusion injury in murine cardiac grafts (2002) (0)
494: Changing Trends in Infectious Complications among Heart Transplant Recipients (2009) (0)
Robbins Sets Goal of 250 New Donors for 2019 UA Cares Campaign (2019) (0)
MHC-I expression on donor allogeneic embryonic stem cells transplanted for myocardial repair correlates with indices of differentiation (2004) (0)
Chronic Pulmonary Allograft Rejection After Successful Bilateral Lung Transplantation (1998) (0)
12: ABO Minor Mismatch in Lung Transplantation – An Analysis of the UNOS Database (2009) (0)
Abstract 3572: Enhancing HIF-1a by Double shRNA Knockdown in Murine Myocardial Infarction (2009) (0)
51: Identifying PKC Epsilon as a Target Molecule To Control Intimal Hyperplasia (2009) (0)
Do S100A4+ cells contribute to the development of obliterative airway disease? (2014) (0)
Development of a novel platform device for reliable and reproducible rodent echocardiography (2006) (0)
Abstract 2368: Long-term Apelin Infusion Rescues Chronic Cardiomyopathy and Potentiates the Effects of ACE-Inhibition (2006) (0)
complication of bicaval anastomoses Superior vena cava syndrome after heart transplantation: percutaneous treatment of a (2013) (0)
Mesenchymal stem cell migration in a murine model of myocardial infarction (2012) (0)
351 The JAK1/3-Inhibitor R507 Diminishes Acute and Chronic Rejection While Demonstrating Immune Cell Specificity (2011) (0)
Immunobiology of naïve and genetically-modified HLA I knockdown human embryonic stem cells (2012) (0)
339: Anti-Apoptotic Role of IL-16 Associated with Attenuation of Acute and Chronic Cardiac Rejection (2010) (0)
Abstract 463: Hypoxia is a Primary Stimulus for Up-Regulation of the Apelin-APJ Cardio-Regulatory Pathway (2006) (0)
237: HGF or VEGF Gene Transfer Maximizes Mesenchymal Stem Cell-Based Myocardial Salvage after Acute Myocardial Infarction (2010) (0)
GENETIC DETERMINANTS OF DRAMATIC IMPROVEMENT IN LEFT VENTRICULAR FUNCTION IN PATIENTS WITH HEART FAILURE (2011) (0)
CHAPTER 8 micro Computed Tomography for Characterization of murine Cardiovascular Disease models (2010) (0)
Bioluminescence Imaging for Monitoring of Engineered Heart Tissue (2011) (0)
Abstract 11908: Assessment of Immunobiology of Fibrin-based Engineered Heart Tissue (2012) (0)
547 Hypoimmunogeneic HLA I Knockdown Human Embryonic Stem Cells Induce Host Ignorance and Achieve Prolonged Xenogeneic Survival (2011) (0)
Cardiac Bioassist: Edited by Alain F. Carpentier, MD, PhD, Juan Carlos Chachques, MD, PhD, and Pierre A. Grandjean, MS, Armonk, NY, Futura Publishing Co Inc, 1997, 632 pp, illustrated, $125, ISBN: 0-87993-647-9 (2000) (0)
Salvage of donor lungs with insufficient left atrial cuffs (2012) (0)
Erratum (2005) (0)
Abstract 3807: Outcomes of Septal Myectomy and Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: The Stanford Experience (2009) (0)
Combined treatment with epsilon protein kinase C activator and delta protein kinase C inhibitor ameliorates ischemia reperfusion injury and graft coronary artery disease in murine cardiac allografts (2004) (0)
Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model. (1998) (0)
Bridge to cardiac transplantation: comparison of LVAD versus inotropic support (2003) (0)
Overexpression of human Bcl-2 attenuates graft coronary artery disease by modulating local th1 immune response but not host immune response in murine cardiac allografts (2004) (0)
T Cell-Mediated Expression of S100A4 Is Associated with Cartilage Disruption in Transplanted Bronchi (2017) (0)
SULFASALAZINE INHIBITS REPERFUSION INJURY AND PROLONGS ALLOGRAFT SURVIVAL IN CARDIAC TRANSPLANTATION.: Abstract# 289 Poster Board #‐Session: P136‐I (2000) (0)
404-1 In vivo magnetic resonance evaluation of the effects of mouse embryonic stem cells on cardiac function (2004) (0)
Using skin transplants as early in vivo indicators for graft rejection in heart transplantation (2012) (0)
356 Pyruvate Dehydrogenase Kinase 2 Controls Vascular Remodeling (2012) (0)
626 Vascular Biology: Dichloroacetate Inhibits the Development of Intimal Hyperplasia, but Not Atherosclerotic Lesions (2012) (0)
Immunobiology of SCNT Derived Embryonic Stem Cells: Pivotal Role of mtDNA in Rejection of Transplanted Stem Cells: 2141 (2012) (0)
Transplantation autoimmunity: the rediscovery of self (2005) (0)
Summarized experimental data on aerosolized tacrolimus immunosuppression for airway transplantation (2009) (0)
IMPROVEMENT IN RIGHT HEART FAILURE AFTER TRICUSPID VALVE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS (1999) (0)
Human embryonic stem cells: immunobiology of naïve cells and their genetically modification (2012) (0)
Nanobiology in Cardiology and Cardiac Surgery (2004) (0)
Strategies to effectively trace transplanted stem cells – How transgenes affect immune responses (2012) (0)
28. A single center experience with heart retransplantation: the 29 year experience at (1997) (0)
In vivo detection and treatment of ischemia-induced cardiac apoptosis using an MRI-detectable molecular probe and an alpha-adrenergic receptor agonist (2012) (0)
460: Inhibition of Restenosis Development by a Novel Drug-Eluting Stent Coated with the Immunosuppressive Leflunomide: Distinct Inhibition of Endothelial and Smooth Muscle Cells (2008) (0)
Marfan syndrome aortic smooth muscle cells express high levels of microRNA miR-29b (2012) (0)
Prevention, inhibition, and reversion of chronic allograft vasculopathy by mitochondrial modulation (2012) (0)
Abstract 11342: Local MicroRNA Modulation is Feasible: A Novel Anti-Mir-21-Eluting Stent Prevents In-Stent Restenosis (2014) (0)
233: The Prevention of Acute Rejection with a Novel JAK Inhibitor (2008) (0)
Dual contrast CMR for evaluation of telmisartan and amlodipine combination therapy in the diabetic murine myocardial injury model (2013) (0)
Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells (2012) (0)
Bioartificial tissue grafts improve left ventricular function in ischemic rat hearts (2005) (0)
Erratum: Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation (Transplantation (July 15, 2005) 80, (134-139)) (2005) (0)
Abstract 5849: The Effects of Statins and Prenylation Inhibitors on Chronic Rejection in Heart Transplantation (2008) (0)
352 Role of Mitochondrial Activity in the Development of Chronic Allograft Vasculopathy (2012) (0)
Does Age Matter? Immunogenic and Biologic Differences between Young and Old Mesenchymal Stromal Cells (2013) (0)
A Common Rejection Module (CRM) across Multiple Transplant Organs Identifies Novel Therapeutics for Treatment of Acute Rejection in Solid Organ Transplantation (2013) (0)
Abstract 3886: Prevention of Dilated Cardiomyopathy with Nitroxides (2008) (0)
In Vivo Imaging of Apoptosis in Early Aneurysm Development in Marfan Syndrome (2012) (0)
A Novel Humanized Model To Study the Development of Obliterative Airway Disease (2013) (0)
563 Identifying the Potassium Channel KCa3.1 as New Therapeutic Target To Prevent Airway Allograft Rejection (2011) (0)
Abstract 16925: In Vivo Crosstalk Between Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Host Myocardial Cells (2013) (0)
355: Mechanical Circulatory Support in Infants, Children and Adolescents as Bridge to Heart Transplantation: Current Outcomes (2008) (0)
No significant homing of IV injected mesenchymal stem cells in a murine model of myocardial infarction (2011) (0)
DUAL CONTRAST CARDIAC MRI FOR EVALUATION OF TELMISARTAN AND AMLODIPINE COMBINATION THERAPY IN THE DIABETIC MURINE MYOCARDIAL INJURY MODEL (2013) (0)
CHAPTER 7 Comparison of Transplantation of Adipose Tissue- and bone m arrow- Derived m esenchymal s tem Cells in the i nfarcted Heart (2009) (0)
Bone marrow-derived mesenchymal stem cells (MSC) can survive in a hypoxic milieu (2008) (0)
Rescue of Suppressed Mitochondrial Superoxide Alleviates Vascular Restenosis (2017) (0)
Improved Heart Transplant Survival in Patients Bridged with Ventricular Assist Device (2002) (0)
632 Clinical Aspects in Regenerative Medicine: Immunobiology of Engineered Heart Tissue (2012) (0)
Abstract 3125: Noninvasive Imaging of Bone Marrow Stem Cell Homing, Survival, and Proliferation in Ischemic Myocardium (2006) (0)
Cardiomyocyte-enriched human embryonic stem cells engraft in ischemic myocardium and support myocardial restoration (2005) (0)
Abstract 16018: Genetic variation near HCRTR2 associates with dramatic improvement of heart function in patients with heart failure (2013) (0)
Immunological and immunomodulatory properties of extra-embryonic tissue-derived mesenchymal stromal cells (2012) (0)
The intermediate-conductance potassium channel as a potential new target for the prevention of airway allograft rejection (2012) (0)
ARGININE POLYMERS INHIBIT GRAFT CORONARY ARTERY DISEASE FOLLOWING CARDIAC TRANSPLANTATION.: Abstract# 726 (2000) (0)
Title Transcriptional and functional profilling of human embryonicstem cell-derived cardiomyocytes (2008) (0)
CYTOPROTECTION AND ISCHEMIA REPERFUSION INJURY: NEW MECHANISTIC ASPECTS (2006) (0)
IS INHALED TACROLIMUS A SAFE TREATMENT OPTION TO PREVENT ACUTE AND CHRONIC REJECTION IN AN AIRWAY TRANSPLANT MODEL?: 1933 (2008) (0)
Abstract 17653: Net Survival Benefit of Heart Transplantation Following Mechanical Circulatory Support in Patients Bridged to Transplant in the Modern Era (2012) (0)
THE ROLE OF CD30 IN ALLOIMMUNE RESPONSES (2004) (0)
405: Cytokine Enhancement with HGF or VEGF in the Infarct Border Zone Is Key to Attenuating the Negative Remodelling after Myocardial Infarction (2009) (0)
Rabbit antithymocyte globulin versus OKT3 induction therapy after heart‐lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis (2001) (0)
TotalLymphoid Irradiation forRefractory AcuteRejection inHeart-Lung andLung (2015) (0)
New Immunosuppression in Experimental Heart and Lung Transplantation: Selective JAK1/3 Inhibition Diminishes Acute Cardiac Rejection and Prevents Obliterative Airway Disease: 2136 (2012) (0)
Host cells contribute to myocardium early, rather than late, after allogeneic and syngeneic murine heart transplantation (2004) (0)
Kinetics of systemic host immune response after experimental heterotopic and orthotopic tracheal transplantations (2009) (0)
229: Novel Immunosuppression: R348, a JAK3- and Syk-Inhibitor, for Prevention of Acute Allograft Rejection (2008) (0)
Abstract 250: In vivo Kinetics of Embryonic Stem Cell Viability Following Transplantation Into the Injured Murine Myocardium (2009) (0)
HAMSTER BLOOD TRANSFUSION CAN INDUCE TOLERANCE TO CARDIAC XENOGRAFTS IN ABSENCE OF T-CELLS (1998) (0)
Muscularization of Pulmonary Arteries Is Reduced in Female Athymic Rats Exposed to Vascular Endothelial Growth Factor Receptor (VEGF-R) Blockade (2014) (0)
Antisense oligonucleotides: design, construction, and applications to cardiac allograft transfer. (2003) (0)
424: BOS-Development: Comparing the Kinetics of Systemic Host Immune Response after Experimental Heterotopic and Orthotopic Tracheal Transplantations (2008) (0)
Production définie chimiquement de cardiomyocytes à partir de cellules souches pluripotentes (2013) (0)
Adenovirus-mediated gene transfer to the rat heart graft. Authors' reply (2004) (0)
Motexafin lutetium in graft coronary artery disease (2000) (0)
330 Regenerative Therapy after Myocardial Infarction: Role of mtDNA in SCNT Derived Embryonic Stem Cells (2012) (0)
Ning Sun Dilated Cardiomyopathy Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial (2012) (0)
Abstract 2326: The Effects of Ischemia-Reperfusion Injury on Bcl-2 (2008) (0)
128: Immunogenicity of Fetal Mesenchymal Stem Cells from the Umbilical Cord Line for Regenerative Therapies (2010) (0)
Indirect imaging of transgene expression using a versatile, bi-directional cardiac gene therapy vector with combined transcriptional targeting and amplification capabilities (2007) (0)
20: The Resuscitated DCD Donor Heart Is Functionally Superior to the Brainstem Dead Donor Heart (2009) (0)
Injectable bioartificial tissue for cell transfer and cardiac repair: Embryonic stem cells for tissue engineering (2004) (0)
What is the immunologic impact after transplantation of a novel fibrin-based type of engineered heart tissue? (2013) (0)
Embryonic stem cell transplantation elicits a primarily Th-1 host T-cell response (2004) (0)
1051-131 Combined treatment with epsilon protein kinase C activator and delta protein kinase C inhibitor ameliorates ischemia reperfusion injury with prolonged ischemia in rat cardiac allografts (2004) (0)
94 Gamma Delta T Cells Contribute to Acute and Chronic Allograft Rejection Via IL-17 Induced Inflammation in a Murine Heart Transplantation Model (2011) (0)
197: 27-Year Experience with Combined Heart-Lung Transplantation at Stanford University (2009) (0)
Abstract 18363: The Human Amniotic Mesenchymal Stem Cell -derived Ipscs Survive and Restore the Injured Hearts in an Immunocompetent Mouse Model of Myocardial Injury (2012) (0)
Tissue engineered, bilayered living skin substitute (Apligraf®) prevents contraction in acute excisional wounds (2006) (0)
Influence of brain death on survival after heart transplantation - time is of the essence (2002) (0)
contribute significantly to formation of new cardiomyocytes in the present study may call into question the mechanistic underpinnings of such trials. A Methods (2004) (0)
288: 20-Year Survivors of Heart Transplantation at Stanford University (2009) (0)
380: Non-Volume-Loaded Heart Provides a More Relevant Heterotopic Transplantation Model (2010) (0)
Stem cell transplantation: Are there age-dependent differences in stem cell behaviour? (2014) (0)
Introducing the first polymer-free leflunomide eluting stent (2009) (0)
Xeno-tolerance induced by blood transfusion in athymic nude rats. (2001) (0)
546 Stem Cell Transplantation: HGF or VEGF Enhance Myocardial Function after Infarction (2011) (0)
Effect of antioxidant vitamins on transplant atherosclerosis in the Zucker rat model: Evidence for oxidative stress in the pathophysiology? (1998) (0)
201: Pharmacokinetics of aerosolized tacrolimus in rats (2007) (0)
Diverse pathways of cardiac allograft rejection correlate with distinct pathogenic mechanisms of cardiac-specific autoimmunity (2005) (0)
393: The Gender Divide: Does Donor Gender Matter for Mesenchymal Stem Cell Transplantation? (2010) (0)
128 Redo Sternotomy in Patients Undergoing Heart Transplantation: A Propensity-Matched Survival Analysis of the United Network for Organ Sharing Database (2012) (0)
Pyruvate dehydrogenase kinase 2 controls the development of intimal hyperplasia (2012) (0)
The Selective JAK1/3 Inhibitor R507 Prevents Acute Rejection and Chronic Obliteration of Transplanted Rat Tracheas (2013) (0)
Preventing mitochondrial dysfunction precludes the development of intimal hyperplasia, but not the development of atherosclerotic lesions (2013) (0)
REGENERATIVE CELLULAR THERAPY: POSITIVE REMODELING AFTER MYOCARDIAL INFARCTION USING IV INJECTED MESENCHYMAL STEM CELLS AND CYTOKINE ENHANCEMENT: 304 (2008) (0)
Abstract 3367: Metformin as a Cardioprotective Agent in Heart Transplantation Decreases Ischemia-Reperfusion Injury and Chronic Rejection (2009) (0)
165 Analysis of over 1000 Patients Listed for Combined Heart-Kidney Transplant in the Modern Era (2012) (0)
Abstract 1433: The Cardioregulatory Peptide Apelin is Preferentially Expressed by Endothelial Cells and Upregulated in Myocardial Disease States (2007) (0)
A novel invasive assessment of the coronary microcirculation (2003) (0)
SUSTAINED RESTORATION OF LV FUNCTION IN A PORCINE ISCHEMIA-REPERFUSION INJURY MODEL USING HUMAN PLACENTAL MESENCHYMAL STEM CELLS AND MANGANESE-ENHANCED MRI (2013) (0)
323: Immunosuppressive Therapy Mitigates Murine T-Cell Mediated Rejection of Human Embryonic Stem Cells Following Transplantation (2008) (0)
Overexpression of neonatal isoform of cardiac myosin in donor hearts results in prolongation of graft survival (2005) (0)
EX VIVO PRESSURE MEDIATED DELIVERY OF NF-KB TRANSCRIPTION FACTOR DECOYS INHIBITS MYOINTIMAL PROLIFERATION ASSOCIATED WITH GRAFT CORONARY ARTERY DISEASE IN CARDIAC ALLOGRAFTS. (1999) (0)
The calcium-activated potassium channel KCa3.1 is critically involved in T cell activation (2013) (0)
Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum (2016) (0)
Metabolic modulation of intimal hyperplasia with Dichloroacetate (2012) (0)
In vivo visualization of transplanted bone marrow mononuclear cell behavior in murine peripheral artery occlusive disease (2010) (0)
Abstract 15289: Apoptosis Participates in Early Aneurysm Development via ECM Remodeling in Marfan Syndrome (2013) (0)
Mitochondrial Activity - a Novel Strategy for Prevention and Reversion of Transplant Vasculopathy: 2113 (2012) (0)
Abstract 2875: Effect of Timing of Bone Marrow Cell Delivery on Cell Viability and Cardiac Recovery Following Myocardial Infarction (2008) (0)
Discussion of pulsatile implantable devices (2001) (0)
Factors associated with long-term survival after heart transplantation in the cyclosporine era (2002) (0)
132: The Role of Mast Cells in Acute and Chronic Cardiac Allograft Rejection (2009) (0)
463: Impact of donor left ventricular hypertrophy on survival after cardiac transplantation (2007) (0)
236: Immunosuppressive Agents Differently Suppress T Cell Subpopulations (2010) (0)
535: Is the malononitrilamide FK778 better for prevention of acute or chronic rejection? (2007) (0)
Regenerative cellular therapy: Positive remodeling after myocardial infarction using iv injected mesenchymal stem cells and cytokine enhancement (2009) (0)
118 Manganese guided cellular MRI enables evaluation of human stromal cell viability (2008) (0)
REGENERATIVE CHANGES OF THE PERI-INFARCT INJURY ALLOWS SUSTAINED RESTORATION OF THE INJURED MYOCARDIUM (2013) (0)
Assessment of immunobiology of engineered heart tissue using bioluminescence imaging (2011) (0)
Happening in August (2017) (0)
Is coronary thermodilution as accurate as doppler velocity for measuring coronary flow reserve (2003) (0)
462: Prevention of Acute Rejection with a Novel Syk Inhibitor (2008) (0)
Electrophysiologic alterations seen in patients with advanced cardiac failure after angiotension converting enzyme inhibitor therapy (2003) (0)
Gene Transfer of Human Bcl-2 in Donor Rodent Lung Allografts Reduces Ischemia/Reperfusion Mediated Inflammatory Response and Apoptosis and Improves Post-Transplant Lung Function (2004) (0)
Controversies surrounding the current status of heart-lung transplantation (1999) (0)
Generation of genetically engineered low-antigenicity MHC I knock-down human embryonic stem cells to prevent immune rejection (2011) (0)
Molecular Imaging of Transcriptionally Targeted and Enhanced Hypoxia-Inducible Factor-1 Alpha Gene Therapy for Myocardial Ischemia (2008) (0)
R348, A JAK3 INHIBITOR, IS IMMUNE CELL SPECIFIC AND PRESERVES THE RESPIRATORY EPITHELIUM WHILE STABILIZING MUCIN GENE 4 (MUC4) EXPRESSION IN THE PREVENTION OF OBLITERATIVE AIRWAY DISEASE (OAD): 1949 (2008) (0)
Manganese-Enhanced cardiac MRI (MEMRI) tracks long-term in vivo survival and restorative benefit of transplanted human Amnion-Derived Mesenchymal Stem Cells (hAMSC) after porcine ischemia-reperfusion injury (2013) (0)
347: Generation of Genetically Engineered Low-Antigenicity MHC I Knock-Down Human Embryonic Stem Cells To Prevent Immune Rejection (2010) (0)
Abstract 281: Local MicroRNA Modulation Using a Novel Anti-mir-21-eluting Stent Effectively Prevents In-stent Restenosis (2015) (0)
272: Use of tacrolimus, sirolimus, and FK778 in experimental xenotransplantation – a detailed analysis of drug efficacy on cellular and humoral xenorejection (2007) (0)
192: Mechanisms behind Local Immunosuppression Using Inhaled Tacrolimus in Preclinical Models of Lung Transplantation (2010) (0)
GRAFT VASCULAR DISEASE (GVD) IN NON HUMAN PRIMATES: QUANTITATION OF CHANGES IN ARTERIAL AUTO- AND ALLOGRAFTS BY INTRAVASCULAR ULTRASOUND (IVUS) (1998) (0)
NUCLEAR FACTOR-&kgr;B TRANSCRIPTION FACTOR DECOY TREATMENT INHIBITS GRAFT CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IN RODENTS1 (2000) (0)
Regenerative Stem Cell Transplantation: Biological and Immunogenic Differences Between Infant and Aged Cells (2014) (0)
Chapter 8 Gene Silencing of prolyl hydroxylase-2 using a minicircle vector carrying short hairpin RNA against PHD 2 improves post-ischemic neovascularization (2011) (0)
Local microRNA Modulation is a Suitable Way to Prevent In-Stent Restenosis and Coronary Allograft Arteriosclerosis (2017) (0)
Chapter 21. Heart Transplantation (2009) (0)
Detection of Apoptosis for the Noninvasive Diagnosis of Cardiac Allograft Rejection (2001) (0)
Obliterans Syndrome? Are Heart-Lung Transplant Recipients Protected From Developing Bronchiolitis (2013) (0)
Abstract 4748: Identifying PKC Epsilon as a Target Molecule to Control Intimal Hyperplasia (2009) (0)
Lowering Asymmetric Dimethylarginine (ADMA) concentrations suppresses graft coronary artery disease in a murine heterotopic heart transplantation model (2007) (0)
426: Imaging Acute Rejection and Graft Revascularization with Bioluminescence Imaging (2008) (0)
Perioperative Drug Reactions in Cystic Fibrosis Lung Transplant Recipients (1998) (0)
Impaired vascular distensibility prior to intimal proliferation in transplant vasculopathy (1998) (0)
Response: Adenovirus-Mediated Gene Transfer to the Rat Heart Graft (2004) (0)
Adenoviral overexpression of human BCL-2 in donor rodent lung allografts reduces ischemia/reperfusion injury and improves post-transplant lung function (2004) (0)
Pharmacokinetics of aerosolized tacrolimus in rats (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert Clayton Robbins?

Robert Clayton Robbins is affiliated with the following schools:

Robert Clayton Robbins's Academic­Influence.com Rankings

Robert Clayton Robbins's Degrees

Why Is Robert Clayton Robbins Influential?

Robert Clayton Robbins's Published Works

Published Works

What Schools Are Affiliated With Robert Clayton Robbins?

Robert Clayton Robbins's AcademicInfluence.com Rankings